期刊文献+

Aβ_(1-15)疫苗免疫接种成年恒河猴的体液免疫效应 被引量:8

Specific humoral immune responses in adult rhesus monkeys vac cinated with Aβ_(1-15) peptide vaccine
暂未订购
导出
摘要 目的:观察Aβ1-15疫苗免疫接种成年恒河猴的特异性体液免疫应答。方法:5只雄性成年恒河猴分别在0、2、6、10、14、18、2 2周肌肉注射法接种Aβ1-15疫苗;ELISA法检测恒河猴血清抗Aβ1-42 抗体及其IgG亚型的水平;Westernblot法检测血清Aβ1-42 抗体的特异性;免疫组化方法观察抗血清与Tg2 5 76转基因鼠脑Aβ斑的识别。结果:疫苗接种后第8周,恒河猴血清中出现明显的抗Aβ1-42 抗体,抗体滴度随接种次数的增加而升高,第2 4周达1∶384 0 ,疫苗停止接种后抗体水平开始下降;血清抗Aβ1-42 IgG以IgG1为主;血清Aβ1-42 抗体具有高度特异性;抗血清可识别结合Tg2 5 76转基因鼠脑组织的Aβ斑。结论:Aβ1-15疫苗可有效诱导成年恒河猴产生特异性体液免疫应答。 AIM: To observe the humoral immune response in adult rhesus monkey induced by Aβ 1-15 vaccine. METHODS: 5 adult male rhesus monkeys were injected intramuscularly with Aβ 1-15 vac cine at baseline and at week 2, 6, 10, 14, 18, 22. The titer and IgG isotypes of the antibody against Aβ 1-42 in the serum were measured with ELISA. The specificity of the antibody against Aβ 1-42 was determined by Wester n blotting. The Aβ plaques in Tg2576 transgenic mouse brain were stained with t he antisera using immunohistochemistry method. RESULTS: At the eighth week after the vaccination, antibody against Aβ 1-42 bega n to develop significantly i n the serum. The titers of the antibody increased following vaccine boosted and reached 1: 3 840 at the twenty-fourth week, then decreased after the terminat ion o f inocunation. The IgG1 was accounted for the highest level in the antisera pool . The antibody against Aβ 1-42 showed high specificity. The Aβ plaques in Tg2576 transgenic mouse brain were labeled with the antisera. CONCLUSION: Aβ 1-15 vacci ne could induce vigorously specific humoral immune responses in adult rhesus mon key.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2005年第4期761-764,共4页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目 (No .30 4 0 0 5 12 ) 广东省自然科学基金重大项目 (No.2 0 0 13137) 广东省自然科学基金资助项目 (No .0 4 30 0 2 18) 广州市科技局项目 (No .2 0 0 4Z3-E0 15 1) 中山市科技局重点攻关项目 (No.4 2 0 96 0 6 )
关键词 阿尔茨海默病 淀粉样肽 疫苗 恒河猴 Alzheimer's disease Amyloid peptide Vac cine Macaca mulatta
  • 相关文献

参考文献14

  • 1林贤,汪华侨,徐杰,姚志彬.Aβ_(42)及其C端亚单位疫苗接种正常SD大鼠后产生高滴度的抗Aβ_(42)抗体[J].解剖学报,2003,34(3):231-235. 被引量:22
  • 2胡金家,汪华侨,曲怀刚,徐杰,姚志彬.Aβ_(42)及亚单位疫苗诱导小鼠抗体产生及其中和Aβ_(42)的细胞毒性[J].细胞与分子免疫学杂志,2004,20(2):178-181. 被引量:29
  • 3李国营,张革,胡金家,汪华侨,邱国光,姚志彬.APPSWE转基因鼠的繁育及子代鉴定的研究[J].中国病理生理杂志,2004,20(1):113-116. 被引量:18
  • 4Schenk D, Barbour R, Dunn W, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse [J]. Nature, 1999, 400(6740):173-177.
  • 5Janus C, Pearson J, McLaurin J, et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease [J]. Nature, 2000, 408(6815): 979-982.
  • 6Morgan D, Diamond DM, Gottschall PE, et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease [J]. Nature, 2000, 408(6815): 982-985.
  • 7Check E. Nerve inflammation halts trial for Alzheimer's drug [J]. Nature, 2002, 415(6871): 462-465.
  • 8Frenkel D, Katz O, Solomon B. Immunization against Alzheimer' s beta-amyloid plaques via EFRH phage administration [J]. Proc Natl Acad Sci USA, 2000, 97(21): 11455-11459.
  • 9Monsonego A, Maron R, Zota V, et al. Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic nice: implications for the pathogenesis and treatment of Alzheimer's disease [ J]. Proc Natl Acad Sci USA,2001, 98(18): 10273-10278.
  • 10Kensil CR, Patel U, Lennick M, et al. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex[J]. J Immunol, 1991, 146(2): 431-437

二级参考文献24

  • 1Schenk D, Barbour R, Dunn W, et al. Immunization with amyloidbeta attenuates Alzheimer-disease-like pathology in the PDAPP mouse[J]. Nature, 1999, 400(6740): 173 - 177.
  • 2Arendash GW, Gordon MN, Diamond DM, et al. Behavioral assessment of Alzheimer' s transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition andspatial memory [ J]. DNA Cell Biol, 2001, (11): 737 -744.
  • 3Schenk D. Amyloid-beta immunotherapy for Alzheimer's disease: the endof the beginning [J]. Nat Rev Neurosci, 2002, 3(10): 824 -828.
  • 4Ott G. The adjuvant MF59: the 1998 perspective, clinical, persormanceand mechanism of action [J]. Res immunol, 1998, 149:25 -27.
  • 5J Mclaurin R, Cecal ME, Kierstead, et al. Therapeutically effectiveantibodies against amyliod-β residues 4-10 and inhibit cytotoxity andfibrillogenesis [ J ]. Nat Med, 2002, 8 ( 11 ): 1263 - 1269.
  • 6Ott G, Barchfeld GL, Van Nest G, et al. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59 [J]. Vaccine, 1995, 13(16): 1557-1562.
  • 7Plduslo JF, Cunan GL. Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brainbarrier [J]. Neuroreport, 2001, 12(15): 3197-3200.
  • 8Dohart JC, Bales Kr, Gannon KS, et al. Immunizarion reverses memory deficits without reducing brain Aβ burden in Alzheimer' s diseasemodel [J]. Nat Neurosci, 2002, 5 (5): 452 -457.
  • 9Jams AR, Nicoll, David W, et al. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report[J]. NatMed, 2003, 10: 1-5.
  • 10Schenk D, Barbour R, Dunn W, et al. Innunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse[J].[see comments]. Nature, 1999,400 (6740): 173-177.

共引文献48

同被引文献59

引证文献8

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部